Clifford Chance houses a ‘dedicated, attentive and competent’ team, which is known for handling the full spectrum of intellectual property matters, including supplementary protection certificate (SPC) applications and appeals. The group also advises on a broad range of non-contentious issues, including reorganisation projects, and regulatory mandates concerning the advertising of medicinal products. The Barcelona-based practice is jointly led by: Miquel Montañá, a dispute resolution specialist who frequently acts for global pharma clients in patent infringement actions involving generics; Josep Montefusco, who is particularly adept in preliminary injunction applications; Guillermo Guardia, who regularly advises on acquisition and corporate financing transactions, with an emphasis on cross-border M&A; and Carme Briera, who focuses on administrative and public law-related matters. Adrián Crespo is noted for his deep knowledge of IP and unfair competition litigation, particularly in relation to pharma and biotech patents.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘The team is very professional. In the pharmaceutical area, they are very knowledgeable. They are also very good in procedural matters.’
- ‘Josep Montefusco has a lot of experience in this field.’
- ‘Josep Montefusco is friendly, supportive and easy to work with. He is also creative in his strategy. It was fun to work with him.’
‘Excellent. Made up of dedicated, attentive and competent professionals.’
‘Professionals who are always inclined to improve the client experience, both from a professional and human point of view. ’
‘Clifford Chance is our go-to law firm in Spain. They are excellent strategically, diligent and easy to work with.’
‘Jospe Monetfusco and Adrián Crespo are the key individuals with whom we work a lot.’
Key clients
- Exact Sciences
- Illumina Cambridge Limited
- Edwards Lifesciences
- UCB Pharma
- Esteve HealthCare
- Bial Portela & Cª, S.A.
- AstraZeneca
- Pfizer Inc
- Novartis
- F. Hoffmann-Roche
- GlaxoSmithKline
- BioNtech
- Theratecnologies
- Grunenthal
- Daiichi Sankyo
- Menarini
- Teva
- Biogen
- Boehringer Ingelheim
- Astellas
- Nutrition & Santé
- Neuraxpharm
- Alexion Pharmaceuticals Inc
- Pharma Mar, SA
Work highlights
- Advised Pfizer Inc. on a reorganisation project (Project OFG- Organization for Growth) consisting in the separation of its consumer health and establishment division of the group.
- Advised Theratecnologies on the regulatory aspects related to the advertising of medicinal products for professionals with respect to a specific medicinal product to be launched for the treatment of cancer.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Carme Briera
Clifford ChancePractice head
The lawyer(s) leading their teams.
Miquel Montañá, Josep Montefusco, Guillermo Guardia, Carme Briera